Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study
暂无分享,去创建一个
N. Bornfeld | D. Lohmann | M. Zeschnigk | C. Pütter | S. Thomas | S. Weber | N. Bornfeld | Norbert Bornfeld
[1] Mohammed F. Faramawi,et al. Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma , 2011, Modern Pathology.
[2] C. Shields,et al. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. , 2011, Ophthalmology.
[3] B. Damato,et al. Genotypic Profiling of 452 Choroidal Melanomas with Multiplex Ligation-Dependent Probe Amplification , 2010, Clinical Cancer Research.
[4] B. Damato,et al. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. , 2010, Investigative ophthalmology & visual science.
[5] J. Harbour,et al. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. , 2010, The Journal of molecular diagnostics : JMD.
[6] A. Stanton,et al. Reactions to and Desire for Prognostic Testing in Choroidal Melanoma Patients , 2009, Journal of Genetic Counseling.
[7] B. Damato,et al. Translating uveal melanoma cytogenetics into clinical care. , 2009, Archives of ophthalmology.
[8] Arie Perry,et al. Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma , 2007, Clinical Cancer Research.
[9] I. Rennie,et al. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma , 2006, Eye.
[10] Justis P. Ehlers,et al. Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death , 2004, Cancer Research.
[11] T. Kivelä,et al. Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.
[12] K. Jöckel,et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. , 2003, Cancer research.
[13] I. Grierson,et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. , 2003, Investigative ophthalmology & visual science.
[14] K. Bartz-Schmidt,et al. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. , 2001, Cancer research.
[15] B. Horsthemke,et al. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. , 2000, Cancer genetics and cytogenetics.
[16] D. Sidransky,et al. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. , 1999, Cancer Research.
[17] D. Horsman,et al. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma , 1998, Cancer.
[18] R. Rees,et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis , 1997, Genes, chromosomes & cancer.
[19] N. Bornfeld,et al. Prognostic implications of monosomy 3 in uveal melanoma , 1996, The Lancet.
[20] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[21] H. V. van Peperzeel,et al. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. , 1982, Human pathology.